Certolizumab Pegol

Cimzia

Tumor Necrosis Factor Blocker

NADAC/unit $6072.5137

No Shortage Tier 1: 31.0% PA Req: 103.0%

Certolizumab Pegol suppresses inflammation by blocking tumor necrosis factor, used in autoimmune conditions.

vs. brand Cimzia: Generic saves up to -60625% per unit

Covered Lives

Explore in the Ecosystem

rxsaver.aiCompare prices for Certolizumab Pegol drfinder.aiFind doctors who prescribe Certolizumab Pegol rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Certolizumab Pegol

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.